What question did this study set out to answer?

The research aims to investigate how neutral endopeptidase (NEP) inhibitors influence natriuretic peptide levels and blood pressure.

Potentiation of Natriuretic Peptides by Neutral Endopeptidase Inhibitors

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial finds enhanced natriuretic peptide activity in hypertensive models, suggesting potential for blood pressure regulation.

The research aims to investigate how neutral endopeptidase (NEP) inhibitors influence natriuretic peptide levels and blood pressure.
Evaluated selective NEP inhibitor SQ 28603 in conscious animal models including monkeys, spontaneously hypertensive rats, and dogs.
Analyzed the effects of NEP inhibition on plasma ANP levels, urine cyclic GMP, sodium excretion, and blood pressure.
Combined NEP inhibition with angiotensin converting enzyme (ACE) inhibition to assess their synergistic effects.
SQ 28603 significantly increased plasma ANP levels and urinary excretion of cyclic GMP and sodium.
NEP inhibitors lowered blood pressure in DOCA/salt hypertensive rats and SHR, comparable to exogenous ANP.
Combined NEP and ACE inhibition improved renal function and cardiac output in heart failure models.

Seymour et al. (1995) studied this question.

View Full Paper

Ask AI

Bookmark